Osteonecrosis

Osteonecrosis is a pathological condition characterized by necrosis of bone tissue, which occurs as a result of insufficient blood supply. This disease causes destruction of bone areas, which in turn can lead to significant pain symptoms, dysfunction of the joint and, in severe cases, to its disability. Osteonecrosis can affect various parts of the body, but its presence in the head of the femur, humerus and other large joints is of greatest importance. It is important to note that osteonecrosis can be both idiopathic and secondary, associated with various systemic diseases, injuries or the action of toxic substances.

History of the disease and interesting historical facts

Osteonecrosis has been described in the medical literature since the early 20th century. In the 1920s, doctors began to study the condition, which occurs in the femur, in more detail. In 1930, Australian surgeon Archibald McBride coined the term avascular necrosis (also known as osteonecrosis) to describe bone death due to a lack of blood supply. Since then, the study of the disease has evolved, and various theories have emerged about its pathogenesis. In the 1970s, it became apparent that osteonecrosis has many causes, including alcohol intoxication, steroid use, and trauma. In recent decades, researchers have focused on the clinical implications of osteonecrosis and its treatments, leading to the development of innovative approaches and technologies to improve the prognosis for patients.

Epidemiology

Osteonecrosis is a global problem, occurring in 10-30% of adult patients with joint disease, according to studies. Osteonecrosis of the femoral head, for example, occurs with a frequency of 1 to 10 cases per 100,000 population per year. Men are more susceptible to the disease than women, with a gender ratio of about 2:1. In certain groups, such as people with systemic lupus erythematosus or organ transplant recipients receiving corticosteroids, the incidence rate can increase significantly. For example, several studies have found that osteonecrosis occurs in approximately 30-50% patients receiving high doses of steroids over a long period of time.

Genetic predisposition to this disease

Evidence of genetic predisposition to osteonecrosis is very limited, but there are data on some genes and mutations associated with this disease. In particular, a study showed that polymorphisms of the VEGF (vascular endothelial growth factor) gene can affect the risk of developing osteonecrosis. Patients with certain variants of this gene have a pronounced predisposition to the pathology. In addition, some mutations in genes associated with lipid and bone metabolism can also contribute to the development of osteonecrosis. However, genetic aspects require further study, and more data are needed to confirm the statistical significance of these associations.

Risk factors for the development of this disease

There are many risk factors associated with the development of osteonecrosis, including:

• Smoking: Nicotine and other toxic substances significantly reduce the blood supply to tissues.
• Alcohol: Excessive alcohol consumption can cause damage to bones and blood vessels.
• Corticosteroids: Long-term steroid use is one of the major risk factors for osteonecrosis.
• Trauma: Fractures and dislocations can damage the blood supply to bone tissue, increasing the risk of necrosis.
• Systemic diseases: Systemic lupus erythematosus, diabetes mellitus, and hematological diseases may contribute to the development of osteonecrosis.
• Long-term compression: Staying in a stationary position can lead to insufficient blood supply.

Diagnosis of this disease

To diagnose osteonecrosis, both clinical symptoms and laboratory and radiological findings must be considered. The main symptoms include:

• Pain in the area of the affected joint, especially under load.
• Limited range of motion in the joint.
• Deterioration of limb function.

Laboratory tests may include complete blood counts and biochemical markers, but they are not specific for the diagnosis of osteonecrosis. Radiological examinations such as X-rays, magnetic resonance imaging (MRI), and computed tomography (CT) are necessary to visualize the affected area. MRI in particular is the most sensitive method for the early diagnosis of osteonecrosis. Differential diagnosis should include other joint diseases such as arthritis, osteoarthritis, and benign and malignant bone tumors.

Treatment

Treatment of osteonecrosis depends on the stage of the disease and includes both conservative and surgical methods. In the early stages of the disease, general treatment is used, including:

• Pharmacological therapy: Nonsteroidal anti-inflammatory drugs (NSAIDs) are used to reduce pain and inflammation.
• Physical therapy: Exercises aimed at strengthening the muscles around the affected joint.
• Lifestyle changes: Quit smoking, limit alcohol consumption and adjust your physical activity regimen.

Surgical treatment may be indicated in more advanced cases and includes:

• Bone grafts: Involves replacing damaged bone tissue.
• Endoprosthetics: Installation of an artificial joint in case of severe joint deformation.
• Trepanation (mecarotopic decompression): A procedure aimed at restoring blood circulation in the area of necrosis.

List of medications used to treat this disease

In therapeutic practice, various types of drugs are used, including:

• NSAIDs (eg, ibuprofen, diclofenac) to relieve pain.
• Corticosteroids (eg, prednisone) for acute conditions.
• Additional drugs such as bisphosphonates to improve bone mineralization.

Disease monitoring

Monitoring of osteonecrosis involves regular examinations to assess progression and effectiveness of treatment. An important aspect is monitoring changes in the structural integrity of the bones using radiological methods, especially MRI. The prognosis depends on the time of treatment and the stage of the disease, but complications such as permanent joint weakness, risk of osteoarthritis and the need for surgical intervention are possible.

Age-related features of the disease

Osteonecrosis can manifest itself differently depending on the age category. In young patients, it is most often associated with injuries and excessive loads, while in older people, the pathology can occur against the background of degenerative changes and concomitant diseases, such as osteoporosis and uncontrolled diabetes. In children, osteonecrosis can manifest itself as Legg-Calve-Perthes disease, leading to weakness in the hip. In adults, osteonecrosis most often affects the femur and humerus. Thus, approaches to treatment and rehabilitation also depend on the patient's age.

Questions and Answers

• What is osteonecrosis? Osteonecrosis is the necrosis of bone tissue resulting from insufficient blood supply, which can lead to pain and functional impairment of the joint.
• What are the main causes of osteonecrosis? The main causes of osteonecrosis are trauma, corticosteroid use, alcohol, and diseases such as diabetes and systemic lupus erythematosus.
• What diagnostic tests are used for osteonecrosis? Diagnosis includes clinical examination, X-rays, MRI, and laboratory tests to rule out concomitant diseases.
• How is osteonecrosis treated? Treatment can be conservative (drug therapy and physiotherapy) and surgical (bone tissue transplantation or endoprosthetics), depending on the stage of the disease.
• What is the prognosis for patients with osteonecrosis? The prognosis depends on the stage of the disease and the time of initiation of treatment, but without adequate therapy, complications such as osteoarthritis and disability may develop.